nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—urinary bladder cancer	0.449	1	CbGaD
Hydroxyurea—RRM2—Gemcitabine—urinary bladder cancer	0.184	0.495	CbGbCtD
Hydroxyurea—RRM1—Gemcitabine—urinary bladder cancer	0.184	0.495	CbGbCtD
Hydroxyurea—RRM1—Nucleotide Metabolism—POLB—urinary bladder cancer	0.00367	0.0659	CbGpPWpGaD
Hydroxyurea—CYP2D6—Doxorubicin—urinary bladder cancer	0.00345	0.00929	CbGbCtD
Hydroxyurea—RRM2—Nucleotide Metabolism—POLB—urinary bladder cancer	0.00302	0.0542	CbGpPWpGaD
Hydroxyurea—RRM2—prostate gland—urinary bladder cancer	0.00217	0.119	CbGeAlD
Hydroxyurea—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—urinary bladder cancer	0.00213	0.0383	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide Metabolism—RRM2—urinary bladder cancer	0.00204	0.0366	CbGpPWpGaD
Hydroxyurea—RRM1—prostate gland—urinary bladder cancer	0.0018	0.0989	CbGeAlD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00168	0.0302	CbGpPWpGaD
Hydroxyurea—RRM1—seminal vesicle—urinary bladder cancer	0.00153	0.0836	CbGeAlD
Hydroxyurea—CYP2D6—urine—urinary bladder cancer	0.00149	0.0818	CbGeAlD
Hydroxyurea—RRM2—renal system—urinary bladder cancer	0.00148	0.0811	CbGeAlD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00138	0.0249	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.00131	0.0236	CbGpPWpGaD
Hydroxyurea—RRM1—smooth muscle tissue—urinary bladder cancer	0.00128	0.07	CbGeAlD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00124	0.0222	CbGpPWpGaD
Hydroxyurea—RRM1—renal system—urinary bladder cancer	0.00123	0.0674	CbGeAlD
Hydroxyurea—RRM1—urethra—urinary bladder cancer	0.00121	0.0662	CbGeAlD
Hydroxyurea—RRM2—female reproductive system—urinary bladder cancer	0.00118	0.065	CbGeAlD
Hydroxyurea—RRM2—G1/S-Specific Transcription—CCNE1—urinary bladder cancer	0.00108	0.0194	CbGpPWpGaD
Hydroxyurea—RRM2—vagina—urinary bladder cancer	0.00107	0.0588	CbGeAlD
Hydroxyurea—RRM2—G1/S-Specific Transcription—TYMS—urinary bladder cancer	0.00106	0.0191	CbGpPWpGaD
Hydroxyurea—RRM1—female reproductive system—urinary bladder cancer	0.000984	0.054	CbGeAlD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—urinary bladder cancer	0.000946	0.615	CbGdCrCtD
Hydroxyurea—RRM1—vagina—urinary bladder cancer	0.00089	0.0488	CbGeAlD
Hydroxyurea—RRM1—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000844	0.0152	CbGpPWpGaD
Hydroxyurea—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.000805	0.0145	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—XRCC1—urinary bladder cancer	0.000772	0.0139	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000759	0.0136	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000706	0.0127	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000695	0.0125	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RRM2—urinary bladder cancer	0.000695	0.0125	CbGpPWpGaD
Hydroxyurea—RRM2—lymph node—urinary bladder cancer	0.000693	0.038	CbGeAlD
Hydroxyurea—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.000673	0.0121	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000663	0.0119	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000659	0.0118	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—CCNE1—urinary bladder cancer	0.000637	0.0114	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—XRCC1—urinary bladder cancer	0.000636	0.0114	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—TYMS—urinary bladder cancer	0.000625	0.0112	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000625	0.0112	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000604	0.0108	CbGpPWpGaD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—urinary bladder cancer	0.000594	0.386	CbGdCrCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000581	0.0104	CbGpPWpGaD
Hydroxyurea—RRM1—lymph node—urinary bladder cancer	0.000576	0.0316	CbGeAlD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000571	0.0103	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000546	0.00981	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000514	0.00922	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000463	0.00832	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—RB1—urinary bladder cancer	0.000424	0.00761	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000423	0.0076	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CCNE1—urinary bladder cancer	0.00041	0.00736	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—TYMS—urinary bladder cancer	0.000402	0.00723	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000391	0.00702	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000381	0.00685	CbGpPWpGaD
Hydroxyurea—CYP2D6—renal system—urinary bladder cancer	0.000365	0.02	CbGeAlD
Hydroxyurea—RRM1—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000361	0.00649	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—SMC1B—urinary bladder cancer	0.000359	0.00645	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000356	0.00639	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.00035	0.00628	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CCNE1—urinary bladder cancer	0.000337	0.00606	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—PLAU—urinary bladder cancer	0.000332	0.00596	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—TYMS—urinary bladder cancer	0.000331	0.00595	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—ATM—urinary bladder cancer	0.000315	0.00566	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000314	0.00564	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000298	0.00536	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000297	0.00534	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000296	0.00532	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000293	0.00527	CbGpPWpGaD
Hydroxyurea—CYP2D6—female reproductive system—urinary bladder cancer	0.000292	0.016	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.000288	0.00517	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000274	0.00492	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—PLAU—urinary bladder cancer	0.000273	0.00491	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RB1—urinary bladder cancer	0.000273	0.0049	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000273	0.0049	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—ATM—urinary bladder cancer	0.000259	0.00466	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000252	0.00452	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CCNE1—urinary bladder cancer	0.000245	0.0044	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—TYMS—urinary bladder cancer	0.00024	0.00432	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.00024	0.00431	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000239	0.00429	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000237	0.00426	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000225	0.00405	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RB1—urinary bladder cancer	0.000225	0.00403	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000224	0.00403	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000222	0.00399	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000219	0.00394	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000207	0.00372	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	0.000206	0.0037	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000206	0.00369	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—TYMS—urinary bladder cancer	0.000203	0.00364	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.000197	0.00355	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000196	0.00352	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000195	0.00351	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00019	0.00341	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—EP300—urinary bladder cancer	0.000186	0.00335	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000186	0.00335	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—ESPL1—urinary bladder cancer	0.000184	0.0033	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00018	0.00323	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.000176	0.00316	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.00017	0.00306	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000165	0.00297	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—RB1—urinary bladder cancer	0.000163	0.00293	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—urinary bladder cancer	0.000162	0.00292	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000161	0.0029	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	0.000158	0.00284	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000156	0.0028	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000156	0.0028	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—EP300—urinary bladder cancer	0.000154	0.00276	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000146	0.00262	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000145	0.00261	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.000145	0.0026	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000145	0.0026	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	0.000141	0.00254	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.00014	0.00252	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—STAG2—urinary bladder cancer	0.000139	0.0025	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—LIG1—urinary bladder cancer	0.000139	0.0025	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	0.000137	0.00247	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—urinary bladder cancer	0.000134	0.0024	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTZ1—urinary bladder cancer	0.000134	0.0024	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000127	0.00228	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTO2—urinary bladder cancer	0.000127	0.00227	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NAT1—urinary bladder cancer	0.000127	0.00227	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000125	0.00225	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000123	0.0022	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000121	0.00217	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	0.000121	0.00217	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—urinary bladder cancer	0.000117	0.0021	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	0.000116	0.00209	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000116	0.00209	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000116	0.00209	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	0.000116	0.00208	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—UGT2B7—urinary bladder cancer	0.000116	0.00208	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000115	0.00206	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTZ1—urinary bladder cancer	0.00011	0.00198	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000109	0.00196	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000106	0.00191	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000106	0.00191	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000105	0.00188	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP4B1—urinary bladder cancer	0.000104	0.00187	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTO2—urinary bladder cancer	0.000104	0.00187	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NAT1—urinary bladder cancer	0.000104	0.00187	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000104	0.00187	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	0.000102	0.00183	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	9.87e-05	0.00177	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC19A1—urinary bladder cancer	9.84e-05	0.00177	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—SMC1A—urinary bladder cancer	9.76e-05	0.00175	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—urinary bladder cancer	9.71e-05	0.00174	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PRSS3—urinary bladder cancer	9.59e-05	0.00172	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	9.56e-05	0.00172	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	9.55e-05	0.00172	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—UGT2B7—urinary bladder cancer	9.53e-05	0.00171	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	9.43e-05	0.00169	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	9.38e-05	0.00169	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	9.08e-05	0.00163	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	9.06e-05	0.00163	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.64e-05	0.00155	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP4B1—urinary bladder cancer	8.58e-05	0.00154	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	8.4e-05	0.00151	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	8.18e-05	0.00147	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC19A1—urinary bladder cancer	8.11e-05	0.00146	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PRSS3—urinary bladder cancer	7.9e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TYMP—urinary bladder cancer	7.67e-05	0.00138	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	7.56e-05	0.00136	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.53e-05	0.00135	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	7.43e-05	0.00133	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	7.36e-05	0.00132	CbGpPWpGaD
Hydroxyurea—Infection—Fluorouracil—urinary bladder cancer	7.05e-05	0.000677	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—urinary bladder cancer	7.04e-05	0.000677	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.01e-05	0.00126	CbGpPWpGaD
Hydroxyurea—Skin disorder—Gemcitabine—urinary bladder cancer	7.01e-05	0.000674	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—urinary bladder cancer	7e-05	0.000673	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—urinary bladder cancer	6.98e-05	0.000671	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	6.97e-05	0.00067	CcSEcCtD
Hydroxyurea—Nervous system disorder—Fluorouracil—urinary bladder cancer	6.96e-05	0.000669	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.95e-05	0.00125	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Fluorouracil—urinary bladder cancer	6.95e-05	0.000668	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NAT2—urinary bladder cancer	6.94e-05	0.00125	CbGpPWpGaD
Hydroxyurea—Discomfort—Cisplatin—urinary bladder cancer	6.93e-05	0.000666	CcSEcCtD
Hydroxyurea—Anorexia—Gemcitabine—urinary bladder cancer	6.88e-05	0.000661	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—urinary bladder cancer	6.81e-05	0.000654	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—urinary bladder cancer	6.8e-05	0.000654	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—urinary bladder cancer	6.79e-05	0.000652	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—urinary bladder cancer	6.78e-05	0.000652	CcSEcCtD
Hydroxyurea—Body temperature increased—Thiotepa—urinary bladder cancer	6.78e-05	0.000652	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCNE1—urinary bladder cancer	6.76e-05	0.00121	CbGpPWpGaD
Hydroxyurea—Anorexia—Fluorouracil—urinary bladder cancer	6.76e-05	0.00065	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—urinary bladder cancer	6.76e-05	0.000649	CcSEcCtD
Hydroxyurea—Oedema—Cisplatin—urinary bladder cancer	6.73e-05	0.000646	CcSEcCtD
Hydroxyurea—Infection—Cisplatin—urinary bladder cancer	6.68e-05	0.000642	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TYMS—urinary bladder cancer	6.64e-05	0.00119	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Cisplatin—urinary bladder cancer	6.6e-05	0.000634	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—urinary bladder cancer	6.59e-05	0.000633	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—urinary bladder cancer	6.58e-05	0.000633	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—urinary bladder cancer	6.54e-05	0.000629	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—urinary bladder cancer	6.53e-05	0.000628	CcSEcCtD
Hydroxyurea—Dyspnoea—Gemcitabine—urinary bladder cancer	6.43e-05	0.000618	CcSEcCtD
Hydroxyurea—Somnolence—Gemcitabine—urinary bladder cancer	6.41e-05	0.000616	CcSEcCtD
Hydroxyurea—Anorexia—Cisplatin—urinary bladder cancer	6.41e-05	0.000616	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	6.38e-05	0.000613	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	6.36e-05	0.00114	CbGpPWpGaD
Hydroxyurea—Pancreatitis—Methotrexate—urinary bladder cancer	6.36e-05	0.000612	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—urinary bladder cancer	6.35e-05	0.00061	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—urinary bladder cancer	6.35e-05	0.00061	CcSEcCtD
Hydroxyurea—Dyspnoea—Fluorouracil—urinary bladder cancer	6.33e-05	0.000608	CcSEcCtD
Hydroxyurea—Hypersensitivity—Thiotepa—urinary bladder cancer	6.32e-05	0.000607	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMP—urinary bladder cancer	6.32e-05	0.00113	CbGpPWpGaD
Hydroxyurea—Somnolence—Fluorouracil—urinary bladder cancer	6.31e-05	0.000606	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—urinary bladder cancer	6.28e-05	0.000603	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	6.28e-05	0.00113	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Gemcitabine—urinary bladder cancer	6.27e-05	0.000603	CcSEcCtD
Hydroxyurea—Dyspepsia—Fluorouracil—urinary bladder cancer	6.25e-05	0.0006	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6.23e-05	0.000599	CcSEcCtD
Hydroxyurea—Fatigue—Gemcitabine—urinary bladder cancer	6.22e-05	0.000598	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.18e-05	0.00111	CbGpPWpGaD
Hydroxyurea—Pain—Gemcitabine—urinary bladder cancer	6.17e-05	0.000593	CcSEcCtD
Hydroxyurea—Constipation—Gemcitabine—urinary bladder cancer	6.17e-05	0.000593	CcSEcCtD
Hydroxyurea—Decreased appetite—Fluorouracil—urinary bladder cancer	6.17e-05	0.000593	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—urinary bladder cancer	6.16e-05	0.000592	CcSEcCtD
Hydroxyurea—Asthenia—Thiotepa—urinary bladder cancer	6.15e-05	0.000591	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	6.12e-05	0.000589	CcSEcCtD
Hydroxyurea—Infection—Etoposide—urinary bladder cancer	6.12e-05	0.000588	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—urinary bladder cancer	6.09e-05	0.000585	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—urinary bladder cancer	6.07e-05	0.000583	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—urinary bladder cancer	6.07e-05	0.000583	CcSEcCtD
Hydroxyurea—Pain—Fluorouracil—urinary bladder cancer	6.07e-05	0.000583	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—urinary bladder cancer	6.03e-05	0.00058	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—urinary bladder cancer	6e-05	0.000576	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—RRM2—urinary bladder cancer	5.99e-05	0.00108	CbGpPWpGaD
Hydroxyurea—Skin disorder—Etoposide—urinary bladder cancer	5.98e-05	0.000575	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—urinary bladder cancer	5.95e-05	0.000572	CcSEcCtD
Hydroxyurea—Feeling abnormal—Gemcitabine—urinary bladder cancer	5.95e-05	0.000571	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—urinary bladder cancer	5.88e-05	0.000565	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—urinary bladder cancer	5.87e-05	0.000564	CcSEcCtD
Hydroxyurea—Diarrhoea—Thiotepa—urinary bladder cancer	5.87e-05	0.000564	CcSEcCtD
Hydroxyurea—Decreased appetite—Cisplatin—urinary bladder cancer	5.85e-05	0.000562	CcSEcCtD
Hydroxyurea—Feeling abnormal—Fluorouracil—urinary bladder cancer	5.85e-05	0.000562	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	5.81e-05	0.000558	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	5.79e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TERT—urinary bladder cancer	5.79e-05	0.00104	CbGpPWpGaD
Hydroxyurea—Drowsiness—Methotrexate—urinary bladder cancer	5.79e-05	0.000556	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—urinary bladder cancer	5.79e-05	0.000556	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—urinary bladder cancer	5.79e-05	0.000556	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—urinary bladder cancer	5.77e-05	0.000554	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—urinary bladder cancer	5.75e-05	0.000553	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NAT2—urinary bladder cancer	5.71e-05	0.00103	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Gemcitabine—urinary bladder cancer	5.7e-05	0.000548	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—urinary bladder cancer	5.68e-05	0.000546	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—urinary bladder cancer	5.68e-05	0.000546	CcSEcCtD
Hydroxyurea—Dizziness—Thiotepa—urinary bladder cancer	5.67e-05	0.000545	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—urinary bladder cancer	5.64e-05	0.000542	CcSEcCtD
Hydroxyurea—Body temperature increased—Fluorouracil—urinary bladder cancer	5.61e-05	0.000539	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—HPGDS—urinary bladder cancer	5.54e-05	0.000996	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO2—urinary bladder cancer	5.54e-05	0.000996	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Cisplatin—urinary bladder cancer	5.54e-05	0.000533	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—urinary bladder cancer	5.53e-05	0.000531	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—urinary bladder cancer	5.51e-05	0.00053	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—urinary bladder cancer	5.49e-05	0.000528	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—urinary bladder cancer	5.48e-05	0.000526	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—urinary bladder cancer	5.47e-05	0.000526	CcSEcCtD
Hydroxyurea—Vomiting—Thiotepa—urinary bladder cancer	5.45e-05	0.000524	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—urinary bladder cancer	5.42e-05	0.00052	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—urinary bladder cancer	5.42e-05	0.00052	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—urinary bladder cancer	5.42e-05	0.00052	CcSEcCtD
Hydroxyurea—Rash—Thiotepa—urinary bladder cancer	5.41e-05	0.00052	CcSEcCtD
Hydroxyurea—Dermatitis—Thiotepa—urinary bladder cancer	5.4e-05	0.000519	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTT1—urinary bladder cancer	5.38e-05	0.000966	CbGpPWpGaD
Hydroxyurea—Headache—Thiotepa—urinary bladder cancer	5.37e-05	0.000516	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—urinary bladder cancer	5.36e-05	0.000515	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—urinary bladder cancer	5.34e-05	0.000513	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.32e-05	0.000511	CcSEcCtD
Hydroxyurea—Body temperature increased—Cisplatin—urinary bladder cancer	5.32e-05	0.000511	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—urinary bladder cancer	5.31e-05	0.000511	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—urinary bladder cancer	5.31e-05	0.00051	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—urinary bladder cancer	5.28e-05	0.000507	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—urinary bladder cancer	5.27e-05	0.000506	CcSEcCtD
Hydroxyurea—Pain—Etoposide—urinary bladder cancer	5.27e-05	0.000506	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—urinary bladder cancer	5.25e-05	0.000505	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—urinary bladder cancer	5.25e-05	0.000505	CcSEcCtD
Hydroxyurea—Hypersensitivity—Fluorouracil—urinary bladder cancer	5.23e-05	0.000502	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—urinary bladder cancer	5.22e-05	0.000502	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—ATM—urinary bladder cancer	5.2e-05	0.000934	CbGpPWpGaD
Hydroxyurea—Haemorrhage—Methotrexate—urinary bladder cancer	5.19e-05	0.000499	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDK4—urinary bladder cancer	5.18e-05	0.00093	CbGpPWpGaD
Hydroxyurea—Asthenia—Gemcitabine—urinary bladder cancer	5.18e-05	0.000498	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—urinary bladder cancer	5.12e-05	0.000492	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—urinary bladder cancer	5.11e-05	0.000492	CcSEcCtD
Hydroxyurea—Nausea—Thiotepa—urinary bladder cancer	5.09e-05	0.00049	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	5.09e-05	0.000914	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Etoposide—urinary bladder cancer	5.08e-05	0.000488	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—urinary bladder cancer	5.04e-05	0.000905	CbGpPWpGaD
Hydroxyurea—Infestation—Doxorubicin—urinary bladder cancer	5.01e-05	0.000482	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—urinary bladder cancer	5.01e-05	0.000482	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—urinary bladder cancer	5.01e-05	0.000482	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—urinary bladder cancer	4.96e-05	0.000476	CcSEcCtD
Hydroxyurea—Diarrhoea—Gemcitabine—urinary bladder cancer	4.94e-05	0.000474	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	4.93e-05	0.000886	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	4.91e-05	0.000472	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—urinary bladder cancer	4.89e-05	0.00047	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—urinary bladder cancer	4.88e-05	0.000469	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—urinary bladder cancer	4.87e-05	0.000468	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—urinary bladder cancer	4.86e-05	0.000467	CcSEcCtD
Hydroxyurea—Diarrhoea—Fluorouracil—urinary bladder cancer	4.85e-05	0.000467	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—urinary bladder cancer	4.83e-05	0.000464	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.74e-05	0.000455	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—urinary bladder cancer	4.71e-05	0.000453	CcSEcCtD
Hydroxyurea—Dizziness—Fluorouracil—urinary bladder cancer	4.69e-05	0.000451	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—urinary bladder cancer	4.66e-05	0.000448	CcSEcCtD
Hydroxyurea—Diarrhoea—Cisplatin—urinary bladder cancer	4.6e-05	0.000442	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—urinary bladder cancer	4.59e-05	0.000441	CcSEcCtD
Hydroxyurea—Vomiting—Gemcitabine—urinary bladder cancer	4.59e-05	0.000441	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HPGDS—urinary bladder cancer	4.57e-05	0.00082	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO2—urinary bladder cancer	4.57e-05	0.00082	CbGpPWpGaD
Hydroxyurea—Rash—Gemcitabine—urinary bladder cancer	4.55e-05	0.000437	CcSEcCtD
Hydroxyurea—Dermatitis—Gemcitabine—urinary bladder cancer	4.55e-05	0.000437	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—urinary bladder cancer	4.54e-05	0.000436	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—urinary bladder cancer	4.52e-05	0.000435	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—urinary bladder cancer	4.52e-05	0.000434	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—urinary bladder cancer	4.52e-05	0.000434	CcSEcCtD
Hydroxyurea—Vomiting—Fluorouracil—urinary bladder cancer	4.51e-05	0.000434	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—urinary bladder cancer	4.5e-05	0.000809	CbGpPWpGaD
Hydroxyurea—Haemorrhage—Doxorubicin—urinary bladder cancer	4.5e-05	0.000432	CcSEcCtD
Hydroxyurea—Rash—Fluorouracil—urinary bladder cancer	4.47e-05	0.00043	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NQO1—urinary bladder cancer	4.47e-05	0.000803	CbGpPWpGaD
Hydroxyurea—Dermatitis—Fluorouracil—urinary bladder cancer	4.47e-05	0.00043	CcSEcCtD
Hydroxyurea—Headache—Fluorouracil—urinary bladder cancer	4.44e-05	0.000427	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTT1—urinary bladder cancer	4.43e-05	0.000796	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	4.43e-05	0.000795	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—urinary bladder cancer	4.42e-05	0.000425	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—urinary bladder cancer	4.41e-05	0.000424	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—urinary bladder cancer	4.36e-05	0.000419	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—urinary bladder cancer	4.3e-05	0.000413	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—urinary bladder cancer	4.29e-05	0.000412	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—urinary bladder cancer	4.28e-05	0.000411	CcSEcCtD
Hydroxyurea—Rash—Cisplatin—urinary bladder cancer	4.24e-05	0.000408	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—urinary bladder cancer	4.24e-05	0.000407	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—urinary bladder cancer	4.23e-05	0.000407	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—urinary bladder cancer	4.22e-05	0.000405	CcSEcCtD
Hydroxyurea—Nausea—Fluorouracil—urinary bladder cancer	4.21e-05	0.000405	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.2e-05	0.000403	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—urinary bladder cancer	4.18e-05	0.000402	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—urinary bladder cancer	4.08e-05	0.000392	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—urinary bladder cancer	4.08e-05	0.000392	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—urinary bladder cancer	4.07e-05	0.000392	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—urinary bladder cancer	4.05e-05	0.000389	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—urinary bladder cancer	4.04e-05	0.000388	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—urinary bladder cancer	3.99e-05	0.000384	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—urinary bladder cancer	3.97e-05	0.000382	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—urinary bladder cancer	3.96e-05	0.000711	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.93e-05	0.000377	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—urinary bladder cancer	3.92e-05	0.000377	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—urinary bladder cancer	3.92e-05	0.000376	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—urinary bladder cancer	3.92e-05	0.000376	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—urinary bladder cancer	3.91e-05	0.000376	CcSEcCtD
Hydroxyurea—Rash—Etoposide—urinary bladder cancer	3.88e-05	0.000373	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—urinary bladder cancer	3.88e-05	0.000373	CcSEcCtD
Hydroxyurea—Headache—Etoposide—urinary bladder cancer	3.86e-05	0.000371	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.82e-05	0.000367	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—urinary bladder cancer	3.82e-05	0.000367	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—urinary bladder cancer	3.8e-05	0.000366	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—urinary bladder cancer	3.79e-05	0.000364	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	3.74e-05	0.000672	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—urinary bladder cancer	3.73e-05	0.00067	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NQO1—urinary bladder cancer	3.68e-05	0.000661	CbGpPWpGaD
Hydroxyurea—Convulsion—Epirubicin—urinary bladder cancer	3.67e-05	0.000352	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—urinary bladder cancer	3.67e-05	0.000352	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—urinary bladder cancer	3.66e-05	0.000352	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.63e-05	0.000349	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—urinary bladder cancer	3.62e-05	0.000348	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—urinary bladder cancer	3.62e-05	0.000348	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	3.62e-05	0.00065	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.61e-05	0.000347	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—urinary bladder cancer	3.58e-05	0.000345	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.58e-05	0.000344	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—urinary bladder cancer	3.56e-05	0.000342	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—urinary bladder cancer	3.53e-05	0.000339	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—urinary bladder cancer	3.52e-05	0.000338	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—urinary bladder cancer	3.51e-05	0.000337	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMS—urinary bladder cancer	3.47e-05	0.000623	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—urinary bladder cancer	3.45e-05	0.000332	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—urinary bladder cancer	3.44e-05	0.000618	CbGpPWpGaD
Hydroxyurea—Infection—Epirubicin—urinary bladder cancer	3.43e-05	0.00033	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOR1—urinary bladder cancer	3.43e-05	0.000615	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—urinary bladder cancer	3.43e-05	0.000615	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	3.42e-05	0.000614	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—urinary bladder cancer	3.39e-05	0.000326	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—urinary bladder cancer	3.39e-05	0.000326	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.38e-05	0.000325	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.37e-05	0.000606	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—urinary bladder cancer	3.35e-05	0.000322	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCND1—urinary bladder cancer	3.34e-05	0.000601	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.31e-05	0.000318	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—urinary bladder cancer	3.29e-05	0.000317	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—urinary bladder cancer	3.29e-05	0.000316	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—urinary bladder cancer	3.29e-05	0.000316	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—urinary bladder cancer	3.28e-05	0.000315	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GPX1—urinary bladder cancer	3.28e-05	0.000589	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Methotrexate—urinary bladder cancer	3.25e-05	0.000312	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—urinary bladder cancer	3.24e-05	0.000581	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ERCC2—urinary bladder cancer	3.22e-05	0.000579	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—urinary bladder cancer	3.21e-05	0.000308	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—urinary bladder cancer	3.2e-05	0.000307	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.19e-05	0.000306	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—urinary bladder cancer	3.18e-05	0.000306	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—urinary bladder cancer	3.17e-05	0.000305	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—urinary bladder cancer	3.16e-05	0.000303	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	3.14e-05	0.000565	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.13e-05	0.000301	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.13e-05	0.000301	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—urinary bladder cancer	3.1e-05	0.000298	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.1e-05	0.000557	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—urinary bladder cancer	3.08e-05	0.000296	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—EP300—urinary bladder cancer	3.08e-05	0.000553	CbGpPWpGaD
Hydroxyurea—Somnolence—Epirubicin—urinary bladder cancer	3.07e-05	0.000295	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTP1—urinary bladder cancer	3.07e-05	0.000551	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—urinary bladder cancer	3.05e-05	0.000293	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—urinary bladder cancer	3.04e-05	0.000292	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—urinary bladder cancer	3.04e-05	0.000292	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—MTHFR—urinary bladder cancer	3.03e-05	0.000544	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Epirubicin—urinary bladder cancer	3e-05	0.000289	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—urinary bladder cancer	3e-05	0.000539	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.98e-05	0.000287	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—urinary bladder cancer	2.98e-05	0.000286	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—urinary bladder cancer	2.95e-05	0.000284	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—urinary bladder cancer	2.95e-05	0.000284	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—urinary bladder cancer	2.92e-05	0.00028	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMS—urinary bladder cancer	2.85e-05	0.000513	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—urinary bladder cancer	2.85e-05	0.000274	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—urinary bladder cancer	2.85e-05	0.000274	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—urinary bladder cancer	2.84e-05	0.000273	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTM1—urinary bladder cancer	2.82e-05	0.000507	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR1—urinary bladder cancer	2.82e-05	0.000507	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Doxorubicin—urinary bladder cancer	2.81e-05	0.00027	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—urinary bladder cancer	2.78e-05	0.000267	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.76e-05	0.000265	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—urinary bladder cancer	2.76e-05	0.000265	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—urinary bladder cancer	2.73e-05	0.000263	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—urinary bladder cancer	2.73e-05	0.000263	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—urinary bladder cancer	2.73e-05	0.000262	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—urinary bladder cancer	2.72e-05	0.000261	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GPX1—urinary bladder cancer	2.7e-05	0.000485	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—urinary bladder cancer	2.68e-05	0.000482	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ERCC2—urinary bladder cancer	2.65e-05	0.000476	CbGpPWpGaD
Hydroxyurea—Asthenia—Methotrexate—urinary bladder cancer	2.65e-05	0.000254	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.63e-05	0.000253	CcSEcCtD
Hydroxyurea—Hypersensitivity—Epirubicin—urinary bladder cancer	2.54e-05	0.000245	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—urinary bladder cancer	2.53e-05	0.000243	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—urinary bladder cancer	2.53e-05	0.000243	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MTHFR—urinary bladder cancer	2.49e-05	0.000448	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—urinary bladder cancer	2.48e-05	0.000238	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PPARG—urinary bladder cancer	2.45e-05	0.000441	CbGpPWpGaD
Hydroxyurea—Dizziness—Methotrexate—urinary bladder cancer	2.44e-05	0.000235	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—urinary bladder cancer	2.36e-05	0.000227	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CREBBP—urinary bladder cancer	2.36e-05	0.000424	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.35e-05	0.000226	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—urinary bladder cancer	2.35e-05	0.000226	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—urinary bladder cancer	2.33e-05	0.000224	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—urinary bladder cancer	2.32e-05	0.000223	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—urinary bladder cancer	2.31e-05	0.000222	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—urinary bladder cancer	2.29e-05	0.00022	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—urinary bladder cancer	2.28e-05	0.000219	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TP53—urinary bladder cancer	2.2e-05	0.000396	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—urinary bladder cancer	2.2e-05	0.000211	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—urinary bladder cancer	2.19e-05	0.000211	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—urinary bladder cancer	2.19e-05	0.00021	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—urinary bladder cancer	2.18e-05	0.000209	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—urinary bladder cancer	2.18e-05	0.000209	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—urinary bladder cancer	2.16e-05	0.000208	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—urinary bladder cancer	2.11e-05	0.000203	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	2.1e-05	0.000376	CbGpPWpGaD
Hydroxyurea—Nausea—Epirubicin—urinary bladder cancer	2.05e-05	0.000197	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—urinary bladder cancer	2.03e-05	0.000195	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PPARG—urinary bladder cancer	2.02e-05	0.000363	CbGpPWpGaD
Hydroxyurea—Rash—Doxorubicin—urinary bladder cancer	2.01e-05	0.000194	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—urinary bladder cancer	2.01e-05	0.000193	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—urinary bladder cancer	2e-05	0.000192	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	1.99e-05	0.000357	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT1—urinary bladder cancer	1.99e-05	0.000357	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CREBBP—urinary bladder cancer	1.94e-05	0.000349	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—urinary bladder cancer	1.93e-05	0.000347	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—urinary bladder cancer	1.9e-05	0.000182	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	1.82e-05	0.000326	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—urinary bladder cancer	1.68e-05	0.000303	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.64e-05	0.000294	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—urinary bladder cancer	1.61e-05	0.000289	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—urinary bladder cancer	1.59e-05	0.000286	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.54e-05	0.000277	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.51e-05	0.00027	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—urinary bladder cancer	1.39e-05	0.000249	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—urinary bladder cancer	1.32e-05	0.000238	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.2e-05	0.000216	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.09e-05	0.000195	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RRM2—urinary bladder cancer	9.39e-06	0.000169	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	8.7e-06	0.000156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—urinary bladder cancer	8.7e-06	0.000156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	8.44e-06	0.000152	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NQO1—urinary bladder cancer	7.01e-06	0.000126	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	5.85e-06	0.000105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMS—urinary bladder cancer	5.44e-06	9.77e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	5.37e-06	9.65e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	5.37e-06	9.65e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPX1—urinary bladder cancer	5.15e-06	9.25e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	5.05e-06	9.08e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	4.75e-06	8.53e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—urinary bladder cancer	3.85e-06	6.92e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	3.7e-06	6.65e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.03e-06	5.44e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.64e-06	4.75e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.52e-06	4.53e-05	CbGpPWpGaD
